Thus, the Tau58/2 and 58/4 models are highly suitable to further contribute to the development of new therapeutic strategies as they aid to elucidate the link between tau pathophysiology and motor, behavioral, and cognitive decline, thereby enabling therapeutic target identification and subsequent evaluation of novel treatment possibilities. Here, MAPT is linked to Mental deterioration.